ImmunoGen, inc (IMGN) ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2021 Operating Results
ImmunoGen, inc (NASDAQ: IMGN) Q2 2021 Earnings Conference
24 articles, transcripts, and reports
ImmunoGen, inc (NASDAQ: IMGN) Q2 2021 Earnings Conference
ImmunoGen, inc (NASDAQ: IMGN) Q1 2021 Earnings Conference
Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
ImmunoGen Inc. (NASDAQ: IMGN) last week reported a profit after incurring losses in the first three quarters of last year. The surprise earnings added to…
ImmunoGen Inc. (NASDAQ: IMGN) Q4 2020 earnings call dated Feb. 12, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
Immunogen Inc (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
Immunogen Inc (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per…
ImmunoGen Inc. (IMGN) Q1 2020 earnings call dated May 01, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President and…
Immunogen Inc (IMGN) Q4 2019 earnings call dated Feb 14, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President and Chief…